Venlafaxine-associated psoriasiform palmoplantar keratoderma and subungual hyperkeratosis.
Dalle
S
S
Becuwe
C
C
Balme
B
B
Thomas
L
L
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects; D003511:Cyclohexanols / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D015776:Keratoderma, Palmoplantar, Diffuse / Q000139:chemically induced*; D007642:Keratosis / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D009260:Nail Diseases / Q000139:chemically induced*; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride